Acesso livre
Acesso livre

Cardiologia

Posicionamento científico | Diagnóstico e tratamento de cardiomiopatias raras em pacientes adultos e pediátricos.

4 Mai, 2022 | 13:24h

Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) – International Journal of Cardiology


M-A | Abordagem transradial vs. transfemoral para intervenção coronariana percutânea em pacientes com infarto do miocárdio com elevação do segmento ST.

3 Mai, 2022 | 16:05h

Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis – European Heart Journal – Quality of Care and Clinical Outcomes

 

Comentário no Twitter

 


Revisão | Novas abordagens de exames de imagem para avaliar a vasculatura pulmonar e o coração direito.

3 Mai, 2022 | 16:02h

Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart – Circulation Research (gratuito por tempo limitado)


Controvérsias em “enhanced recovery” após cirurgia cardíaca.

3 Mai, 2022 | 16:01h

Controversies in enhanced recovery after cardiac surgery – Perioperative Medicine

Conteúdos relacionados:

Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations – JAMA Surgery

Expert Consensus of Data Elements for Collection for Enhanced Recovery After Cardiac Surgery – World Journal of Surgery

Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step—But There Is Much Work to Be Done – Cardiothoracic and Vascular Anesthesia

Ver também: Enhanced Recovery After Surgery (ERAS) Society Guidelines


M-A | Reserva de fluxo coronariano e desfechos cardiovasculares.

2 Mai, 2022 | 13:48h

Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis – European Heart Journal

 

Comentário no Twitter

 


M-A | Fibras dietéticas no tratamento da hipertensão e doença cardiovascular.

2 Mai, 2022 | 13:47h

Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses – BMC Medicine


Comentário de estudo | Pessoas de todas as idades se beneficiam de drogas para hipertensão arterial.

2 Mai, 2022 | 13:42h

People of all ages benefit from drugs to lower blood pressure – National Institute for Health and Care Research

Estudo original: Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis – The Lancet


Revisão das evidências e guia prático de uso clínico | Inibidores do cotransportador sódio-glicose 2 na insuficiência cardíaca aguda.

29 Abr, 2022 | 14:58h

Sodium-glucose Co-transporter 2 Inhibitors in Acute Heart Failure: A Review of the Available Evidence and Practical Guidance on Clinical Use – Reviews in Cardiovascular Medicine

 

Comentário no Twitter

 


M-A | Estratégia anticoagulante ótima para tratamento periprocedimento na ablação da fibrilação atrial.

29 Abr, 2022 | 14:45h

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis – Journal of Clinical Medicine


Diretriz da USPSTF | Use de aspirina na prevenção de doença cardiovascular.

28 Abr, 2022 | 12:18h

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement – JAMA

Entrevista com o autor: USPSTF Recommendation: Aspirin Use for Cardiovascular Disease – JAMA

Estudo modelo: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force – JAMA

Relatório de evidência: Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Página do paciente: Use of Aspirin to Prevent Cardiovascular Disease – JAMA

Editoriais:

Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force

Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma – JAMA Internal Medicine

Aspirin for Primary Prevention—Time to Rethink Our Approach – JAMA Network Open

USPSTF Report on Aspirin for Primary Prevention – JAMA Cardiology

Comentários:

USPSTF Report on Aspirin for Primary Prevention – American College of Cardiology

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention – TCTMD

Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says – STAT

U.S. Task Force Rejects Daily Aspirin for Heart Health in People Over 60 – HealthDay


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.